Item 2.02. Results of Operations and Financial Condition.

On September 27, 2021, iBio, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter and year ended June 30, 2021. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information in this Item 2.02 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

The following exhibit is furnished with this Current Report on Form 8-K.




   Exhibit
   Number     Exhibit Description
    99.1        Press Release, issued by iBio, Inc. dated September 27, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses